Literature DB >> 29627442

A novel role of endocan in alleviating LPS-induced acute lung injury.

Xiaolong Zhang1, Rong Zhuang1, Haiya Wu1, Jie Chen1, Fangyan Wang2, Guoping Li3, Chengyun Wu4.   

Abstract

AIMS: Endotoxin induced acute lung injury (ALI) is a critical complication of some clinical illnesses. Endothelial cell dysfunction and excessive pro-inflammation cytokine release are pivotal to the injury of alveolar-capillary membrane which is the typical characteristic of endotoxic lung injury. As a potential marker of endothelial cells, endocan plays an important role in many endothelial-dependent pathophysiological diseases. We speculated that endocan have anti-inflammatory property in ALI. Here, we investigated the role of endocan in LPS-induced ALI.
MATERIALS AND METHODS: Mice were randomly divided into 4 groups. LPS were used to construct ALI mice model by aerosolization for 20 min. Endocan was intraperitoneal injected at 30 min before LPS exposure. Levels of TNF-α, IFN-γ, IL-1β, IL-6 and MPO activities were detected by indicated ELISA. Cell apoptotic rate was determined by Annexin V/PI kit, ROS level and MPTP were detected by DCFH-DA and JC-1 kit, respectively. Seahorse XF96 was applied to evaluate the alteration of OCR and ECAR. Western blot and qRT-PCR were used to detect indicated molecules. KEY
FINDINGS: Endocan effectively decreased TNF-α, IFN-γ, IL-1β, and IL-6 levels as well as relieved pulmonary epithelium cell apoptosis caused by LPS exposure. Endocan significantly reversed LPS induced UPRmt and promoted cell metabolism reprogramming which were crucial for the protective characteristic of endocan in ALI mice model. SIGNIFICANCE: The above findings suggested endocan could significantly suppress inflammatory response in ALI model through attenuating UPRmt associated apoptosis and switch cellular bioenergetics, indicating endocan could be considered as a promising compound against LPS induced ALI.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Acute lung injury; Apoptosis; Cellular bioenergetics; Endocan; LPS; Mitochondrial UPR

Mesh:

Substances:

Year:  2018        PMID: 29627442     DOI: 10.1016/j.lfs.2018.04.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  The association of elevated circulating endocan levels with lung function decline in COPD patients.

Authors:  Luqi Dai; Junyun He; Jun Chen; Tao Wang; Lian Liu; Yongchun Shen; Lei Chen; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-09

2.  Comparison of the TLR4/NFκB and NLRP3 signalling pathways in major organs of the mouse after intravenous injection of lipopolysaccharide.

Authors:  Qin Gong; Luling He; Mulan Wang; Shasha Zuo; Hongwei Gao; Yulin Feng; Lijun Du; Yingying Luo; Jun Li
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

3.  Decreased expression of endothelial cell specific molecule-1 in lung tissue in emphysematous mice and stable COPD patients.

Authors:  Yan Zhang; Ping Chen; Shan Cai; Jinhua Li; Yan Chen
Journal:  Iran J Basic Med Sci       Date:  2020-12       Impact factor: 2.699

Review 4.  Endocan: A Key Player of Cardiovascular Disease.

Authors:  Jinzhi Chen; Liping Jiang; Xiao-Hua Yu; Mi Hu; Yang-Kai Zhang; Xin Liu; Pingping He; Xinping Ouyang
Journal:  Front Cardiovasc Med       Date:  2022-01-05

Review 5.  Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.

Authors:  Nathalie De Freitas Caires; Alexandre Gaudet; Lucie Portier; Anne Tsicopoulos; Daniel Mathieu; Philippe Lassalle
Journal:  Crit Care       Date:  2018-10-26       Impact factor: 9.097

6.  Aerobic Exercise Attenuates Acute Lung Injury Through NET Inhibition.

Authors:  Yue Shi; Tingting Liu; David C Nieman; Yanqiu Cui; Fei Li; Luyu Yang; Hui Shi; Peijie Chen
Journal:  Front Immunol       Date:  2020-03-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.